Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVASTIGMINE Cause Product administration interrupted? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Product administration interrupted have been filed in association with RIVASTIGMINE (Exelon). This represents 0.3% of all adverse event reports for RIVASTIGMINE.

29
Reports of Product administration interrupted with RIVASTIGMINE
0.3%
of all RIVASTIGMINE reports
2
Deaths
3
Hospitalizations

How Dangerous Is Product administration interrupted From RIVASTIGMINE?

Of the 29 reports, 2 (6.9%) resulted in death, 3 (10.3%) required hospitalization.

Is Product administration interrupted Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVASTIGMINE. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does RIVASTIGMINE Cause?

Death (1,229) Fall (587) Malaise (514) Drug ineffective (510) Product adhesion issue (478) Vomiting (432) Dementia alzheimer's type (428) Memory impairment (385) Nausea (383) Pneumonia (378)

What Other Drugs Cause Product administration interrupted?

CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (1,446) SODIUM OXYBATE (1,272) CANNABIDIOL (511) ISOTRETINOIN (503) APREMILAST (314) TREPROSTINIL (295) EPOPROSTENOL (205) LENALIDOMIDE (146) ETANERCEPT (142) INTERFERON BETA-1A (115)

Which RIVASTIGMINE Alternatives Have Lower Product administration interrupted Risk?

RIVASTIGMINE vs RIVOTRIL RIVASTIGMINE vs RIZATRIPTAN RIVASTIGMINE vs ROACTEMRA RIVASTIGMINE vs ROCURONIUM RIVASTIGMINE vs ROFECOXIB

Related Pages

RIVASTIGMINE Full Profile All Product administration interrupted Reports All Drugs Causing Product administration interrupted RIVASTIGMINE Demographics